Business
Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications
- Data is from comprehensive review of hospital charges and all-payer claims over five years - - Preventable complications such as amputation and conduit infection increased initial hospital charges by approximately $493,000 and $590,000 per patient respectively – - Humacyte’s Symvess® has consistently demonstrated low rates of infection and high rates of limb salvage – DURHAM, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform compan
About this update from Humacyte, Inc.
[{"type":"image","alt":"Humacyte, Inc","displaySize":"","headline":null,"caption":"Humacyte, Inc","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":57,"url":"https://media.zenfs.com/en/globenewswire.com/6664e34870555953d37f7abc79cd102e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/trBSY4KWXHpBRzQ_5qCqbw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTgwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6664e34870555953d37f7abc79cd102e","width":300,"height":57}},"lazy":false},{"type":"text","content":"- Data is from comprehensive review of hospital charges and all-payer claims over five years - ","length":94,"tagName":"p"},{"type":"text","content":"- Preventable complications such as amputation and conduit infection increased initial hospital charges by approximately $493,000 and $590,000 per patient respectively –","length":169,"tagName":"p"},{"type":"text","content":"- Humacyte’s Symvess® has consistently demonstrated low rates of infection and high rates of limb salvage – ","length":107,"tagName":"p"},{"type":"text","content":"DURHAM, N.C., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the results of a five-year retrospective analysis of hospital charges, payer costs, and healthcare resource utilization in patients with extremity arterial injury. The average hospital charge for extremity arterial injury repair during initial hospitalization was $316,600 per patient, and amputations and infections increased the average hospital charge per patient by $492,986 and $589,921, respectively. Humacyte’s Symvess (acellular tissue engineered vessel) has consistently demonstrated low rates of conduit infection and high rates of limb salvage in the treatment of extremity arterial injury. ","length":844,"tagName":"p"},{"type":"text","content":"Data from two linked databases (Premier Inc. Healthcare Database and Inovalon all-payer claims database) included hospital charges and reimbursed costs in 964 adult patients with extremity arterial injuries that required surgical repair. Patients undergoing extremity arterial injury repairs using autologous vein, synthetic grafts, and other biological conduits were included, from 2018-2023. All data were co...